Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.75B |
| 2 |
Microsoft
MSFT
|
+$1.78B |
| 3 |
Fortive
FTV
|
+$1.26B |
| 4 |
AGN
Allergan plc
AGN
|
+$797M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.98B |
| 2 |
Danaher
DHR
|
+$1.61B |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$1.56B |
| 4 |
McDonald's
MCD
|
+$972M |
| 5 |
CELG
Celgene Corp
CELG
|
+$940M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.65% |
| 2 | Technology | 15.07% |
| 3 | Financials | 13.7% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Perrigo
PRGO
$1.86B
| $76.7M | 0.01% |
830,795
+269,734
| +48% | +$24.9M |
|
|
TMHC
1102
DELISTED
Taylor Morrison
TMHC
| $76.5M | 0.01% |
4,347,525
-435,403
| -9% | -$7.35M |
|
1103
Expeditors International
EXPD
$23.7B
| $76.3M | 0.01% |
1,481,719
+1,080,407
| +269% | +$54.7M |
|
|
TMUSP
1104
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $76.3M | 0.01% |
977,385
-240,400
| -20% | -$18.6M |
|
1105
Marathon Petroleum
MPC
$87.8B
| $76.1M | 0.01% |
1,875,389
+251,660
| +15% | +$10.2M |
|
|
GNMK
1106
DELISTED
GenMark Diagnostics, Inc
GNMK
| $76.1M | 0.01% |
6,449,083
+30,945
| +0.5% | +$299K |
|
1107
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.73B
| $76M | 0.01% |
1,640,400
+25,253
| +2% | +$1.15M |
|
|
WPX
1108
DELISTED
WPX Energy, Inc.
WPX
| $76M | 0.01% |
5,758,630
+2,234,930
| +63% | +$24.8M |
|
1109
Donaldson
DCI
$11.3B
| $75.9M | 0.01% |
2,033,900
-2,500
| -0.1% | -$91.1K |
|
1110
Dine Brands
DIN
$449M
| $75.8M | 0.01% |
957,006
-15,602
| -2% | -$1.24M |
|
1111
Atara Biotherapeutics
ATRA
$76.8M
| $75.6M | 0.01% |
141,376
+16,360
| +13% | +$8.88M |
|
1112
Zions Bancorporation
ZION
$10.5B
| $75.2M | 0.01% |
2,423,988
-586,211
| -19% | -$16.7M |
|
1113
FirstCash
FCFS
$9.07B
| $74.9M | 0.01% |
1,590,214
+329,277
| +26% | +$16.6M |
|
|
FITB
1114
Fifth Third Bancorp
FITB
$52.3B
| $74.7M | 0.01% |
3,653,035
-730,359
| -17% | -$14.1M |
|
1115
ITT
ITT
$18.3B
| $74.7M | 0.01% |
2,084,046
+356,653
| +21% | +$12.2M |
|
1116
Hope Bancorp
HOPE
$1.82B
| $74.6M | 0.01% |
4,295,040
-1,755,639
| -29% | -$28.4M |
|
1117
Leidos
LDOS
$16B
| $74.4M | 0.01% |
1,718,994
+802,235
| +88% | +$36.4M |
|
1118
Seres Therapeutics
MCRB
$47.5M
| $74.2M | 0.01% |
301,944
+5,545
| +2% | +$1.95M |
|
|
LNCE
1119
DELISTED
Snyders-Lance, Inc.
LNCE
| $74.2M | 0.01% |
2,209,488
+203,547
| +10% | +$7.05M |
|
1120
Editas Medicine
EDIT
$422M
| $74M | 0.01% |
5,492,112
+40,051
| +0.7% | +$821K |
|
1121
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$583M
| $74M | 0.01% |
2,984,728
+33,360
| +1% | +$812K |
|
1122
Clearway Energy Class C
CWEN
$4.85B
| $73.9M | 0.01% |
4,355,927
+845,148
| +24% | +$14.5M |
|
|
RSPP
1123
DELISTED
RSP Permian, Inc.
RSPP
| $73.8M | 0.01% |
1,902,208
-27,505
| -1% | -$1.02M |
|
|
AIMT
1124
DELISTED
Aimmune Therapeutics
AIMT
| $73.7M | 0.01% |
4,911,827
+35,260
| +0.7% | +$476K |
|
1125
Prosperity Bancshares
PB
$8.96B
| $73.6M | 0.01% |
1,340,385
-1,176,000
| -47% | -$62.3M |
|
Similar funds
Fidelity Investments's Q3 2016 Portfolio in Review
As of Q3 2016, Fidelity Investments held 2,796 positions worth $751B, up 2.5% from $733B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Fidelity Investments withdrew a net $22.6B in Q3 2016, closing 150 positions and reducing 1,143 holdings. Its most notable exit was EMC CORPORATION, an estimated $1.56B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Fidelity Investments opened a new position in Fortive worth $1.26B.
- Fidelity Investments's largest Q3 2016 buy was Fortive: 39,374,472 shares worth $1.26B.
- Fidelity Investments added most to Apple in Q3 2016, an estimated $2.75B increase.
- Fidelity Investments's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $1.98B.
- Fidelity Investments fully exited EMC CORPORATION in Q3 2016, selling an estimated $1.56B.
- Fidelity Investments's ten largest holdings make up 16% of its $751B portfolio in Q3 2016.
- Fidelity Investments opened 147 new positions and closed 150 in Q3 2016.
- Fidelity Investments's portfolio value rose 2.5% quarter-over-quarter to $751B.
Based on Fidelity Investments's 13F filing for Q3 2016, filed 14 Nov 2016.